scholarly journals ВДОСКОНАЛЕННЯ СИСТЕМИ КОНТРОЛЮ ТА ОБІГУ ГМО В УКРАЇНІ

2016 ◽  
Vol 18 (3(71)) ◽  
pp. 63-65
Author(s):  
B.I. Nazar

The article briefly presents the main approaches to the state registration and order of the state veterinary and sanitary expertise GMO sources of feed, feed additives and veterinary medicinal products are listed feasibility studies to be carried out at the registration of GMO sources listed safety parameters on which the assessment of GMO sources. There need to conduct clinical studies to determine the impact of GMO sources or feed sources, feed ingredients derived from their use on animals. The order defines the procedure for state registration of genetically modified organisms sources of feed, feed additives and veterinary medicinal products containing genetically modified organisms or derived from their use.The basic components and objectives of the integrated system of state monitoring of GMO sources of feed, feed additives, premixes for livestock and poultry. The basic methodological approaches and criteria for the development and implementation in Ukraine of the State monitoring of feed containing GMO sources including requirements for sampling, setting the frequency of sampling and analysis of risks at all stages of the chain «production – consumption» . Based on the analysis of a draft list of feeds, feed raw materials and premixes that must be controlled on content of genetically modified organisms. 

2019 ◽  
Vol 21 (94) ◽  
pp. 152-156
Author(s):  
B. I. Nazar ◽  
H. V. Kushnir ◽  
H. I. Boiko ◽  
S. D. Murska

The article presents the main methodological approaches and criteria for the necessity of development and introduction of the State Registration of GMOs sources in Ukraine. The list of analytical researches that are to be carried out at the registration of the GMO source, expert evaluation of GMO identification methods, reproduction of detection methods, identification and quantification of GMOs are given. Submitted and analyzed legislative documents regulating the procedure for registration and control of GMO circulation in the countries of the European Union and Ukraine. DNDKI of veterinary preparations and fodder supplements on the tasks of the State Committee of Veterinary Medicine of Ukraine during 2010-2018 a number of normative documents were developed regarding procedures related to the use and circulation of feed, feed additives, premixes and veterinary preparations that are composed, containing or made using genetically modified sources in Ukraine: the procedure for state registration, the procedure for carrying out the state veterinary and sanitary examination of GMOs for sources of forage feed additives and veterinary preparations ativ plan state monitoring GMO sources of feed, feed additives, premixes for livestock and poultry. The procedure determines the procedure for state registration of GMOs for sources of feed, feed additives and veterinary preparations containing genetically modified organisms or obtained from their use. It is envisaged that the state register of GMO sources is conducted in the form approved by the State Service of Ukraine for Food Safety and Consumer Protection. On the basis of the analysis, a draft list of feeds, feed materials, protein-vitamin concentrates and premixes that have to be monitored for GMO content has been developed. This project list includes soy, corn, rape and products of their processing, fodder, feed mixes, feed concentrates, etc. In the SSRCI of veterinary drugs and supplements, in 2018, the “Guidelines for identifying the GM soya line (Soybean MON40-3-2) GTS 40-3-2” were developed and approved. “Methodological recommendations are intended to identify the GM soya line (Soybean MON40-3 -2) GTS 40-3-2 (Genetically modified soybean that contains – genetically modified soybean containing (cp4 epsps gene inserted to confer tolerance to herbicide glyphosate) cp4 epsps gene inserted to provide resistance to glyphosate herbicide (glyphosate) in plant material, feed and food products by polymerase chain reaction in real time (PCR-RF )”. The qualitative determination of GMOs is based on the discovery of genetically modified (GM) targeted regulatory sequences of the 35S Cauliflower Mosaic Virus (CaMV) promoter or FMV promoter and/or the NOS (T-NOS) T1 terminator of Agrobacterium tumefaciens plasmids that are introduced into the genetic constructs of GM based on the use of the multiplex polymerase chain reaction method to obtain real-time research results – PCR RF.


Author(s):  
Jourdan Witt

Advancements in synthetic biology have led to the use of genetically modified organisms in research and industrial fields. Bacteria were one of the first organisms to be genetically engineered due to their fast growth and simple genetics, and have emerged as a major scientific and commercial interest. For instance, modified commensal bacteria can be used as an oral delivery vector of therapeutics, or as probiotics to target specific pathogens in the gastrointestinal tract. The impact of the release of pathogens used in research or vaccine development could be catastrophic to the environment and public health. In addition, there is growing concern about using genetically modified organisms in open systems, as there is a possibility for unintentional proliferation into natural environments. Therefore, is imperative that the environmental safety of genetically modified organisms are addressed, and that adequate biocontainment mechanisms are developed.


Author(s):  
A.R. Peters

Legislation to control veterinary medicinal products is undergoing continual development in the EEC and UK and therefore the risks are continually reassessed. In the present paper current and future legislation together with consumer concerns both real and imaginary are reviewed.Since the EEC ban on hormonal growth promoter implants in 1986 the remaining legal products are all feed additives. Registration of feed additives in the EEC is controlled under Directive 70/524 and its various amending directives. this directive is concerned with all products added to feed and mainly includes substances used to affect the quality of the feedstuff i.e., emulsifiers, stabilisers, antioxidants, colorants and binding agents and also vitamins and micronutrients. The majority of growth promoters exert their affects by antimicrobial activity and these and certain prophylactic medicinal products such as coccidiostats are also included. All products with a therapeutic action are controlled under the Veterinary Medicine Directives 81/851 and 81/852, quite separate legislation and under the responsibility of a different department within the EEC Coimdssion. However, there is provision under Directive 84/587 amending 70/524 to transfer the medicinal feed additives to 81/851 and 81/852.


2020 ◽  
Vol 42 (6) ◽  
pp. 747-775
Author(s):  
Ivanka Pjesivac ◽  
Marlit A. Hayslett ◽  
Matthew T. Binford

This study examined the framing of genetically modified organisms in two American newspapers, The New York Times and the Washington Post (2000-2016) and tested the impact of risk and opportunity framing on attitudes and behaviors regarding genetically modified organisms. The content analysis ( N = 165) showed that the two newspapers did not have a dominant frame type in their coverage. A randomized three-condition experiment ( N = 182) showed that the type of framing significantly affected individuals’ attitudes and was able to change them. The type of framing affected individuals’ behavioral intentions through postexposure attitudes but was not able to significantly affect actual behavior.


2012 ◽  
Vol 235 (4) ◽  
pp. 597-610 ◽  
Author(s):  
W. Meyer ◽  
M. Caprioara-Buda ◽  
B. Jeynov ◽  
P. Corbisier ◽  
S. Trapmann ◽  
...  

Author(s):  
Olena KOVAL

The issues of accounting and information provision of management, state and social control over biological assets with genetically modified forms are considered. The method of constructing a separate account of the availability of genetically modified biological assets (GMBA) and operations on their transformations has been developed, ways of improving the quality of the P (S) "Biological Assets" and IAS 41 "Agriculture" have been identified, which lies in the rethinking of the role of agricultural activity for social and environmental and environmental factors of human development. The analysis of accounting standards has shown that in the content of P (S) "Biological Assets" and IAS 41 "Agriculture" there is no information on the procedure for the accounting and control of biological assets and agricultural products from GMOs. In connection with this, it is necessary to find an integrated approach to building a system of accounting for biological assets with genetically modified organisms, in view of increasing public requests for accounting information in the context of sustainable development. Since GMOs are the assets of all agricultural enterprises in the form of biological assets and agricultural products, for the "transparent" accounting of the enterprise it is necessary to reflect them as separate objects of accounting. Mandatory allocation of relevant analytical accounts leads to the introduction of additional articles on genetically modified biological assets in the accounting registers of accounting and statistical reporting. The accounting of biological assets with genetically modified organisms should ensure that accurate information is obtained about the quality and quantity of these assets, and the basis for their reliable assessment. More responsibly should be placed on the disclosure of information on genetically modified biological assets in the Notes to the Financial Statements. We suggest that the accumulated information on biological assets from GMOs be reflected in a separate section in section 16 entitled "Financial Results from Primary Acceptance and Marketing of Agricultural Products from GMOs and Additional Biological Assets with GMOs". The introduction of a separate section in the notes on genetically modified assets will allow obtaining the necessary operational information on these assets for management needs and for the state as a whole. Information on the biological assets of the enterprise and their biological transformations, as well as agricultural products, are reflected in the Form 50-s. "Basic economic indicators of agricultural enterprises". We consider it expedient to supplement it with another section, which will reflect the information on the composition of production and marketing of agricultural products from GMOs. The financial statements of agricultural enterprises require changes in the reflection of the reassessment of biological assets and information on the production and sale of genetically modified assets. Information on GMO biological assets is currently absent from P (S) "Biological Assets" and IAS 41, although it is significant both at the enterprise level and on the basis of the country as a whole. Therefore, we consider it expedient to supplement the contents of the provisions with the section "Environmental safety", which will specify the method of constructing a separate accounting for biological assets with GMOs. Solving the problems of accurately displaying information in accounting and reporting regarding genetically modified biological assets and their biological transformations requires the adoption of new, regulatory and legal decisions by the state. Taking into account the harmonization of Ukraine's legislation with the EU, this statement is quite logical. In this regard, we propose the standard of accounting for agricultural activities to be supplemented with the section "State support", which, in addition to the norms reflected in IAS 41, found a place and provisions to stimulate the production of biological assets and agricultural products without genetically modified organisms.From the above, we believe that at the state level, companies should be required to account for biological assets and agricultural products from GMOs in accounting and reporting. The real steps in this regard are to create, with the help of economic incentives (taxes, loans, privileges, etc.), state support to companies that provide true information on the availability of biological assets from GMOs, the quantity of GM products grown and markets for its sales. Consequently, taking into account the advantages and disadvantages of a new accounting of agricultural activity, having identified the problems of its application in practice, we propose to finalize P (S) 30 "Biological Assets". The revised standard will facilitate more realistic accounting in agriculture and achievement of higher end results of activities in order to ensure the management of reliable and truthful information about the results of activities. Improvement of P (S) 30 "Biological Assets" lies in the rethinking of the role of agricultural activity for social and environmental and environmental factors of human development. The issue of "State support" and "Environmental safety" require separate disclosure in agricultural sectoral standards. The world standardization of accounting and reporting of the production of genetically modified products is also very important


2017 ◽  
Vol 3 (1) ◽  
pp. 57
Author(s):  
Anjali Ghodasara ◽  
Marisa Deliso ◽  
Satesh Bidaisee

This study assessed knowledge, attitudes and perceptions of various stakeholders in Grenada regarding genetically modified organisms and the release of genetically modified mosquitoes. The study adopted a cross sectional design with a study population that comprised of members from seven stakeholder groups of civil society in Grenada. The sample population was obtained through a snowballing strategy and data collection for the study consisted of a semi-structured interview. Data was managed through the collection and reviewing of data from transcribed interview notes, as well as observations and interpretations made during the field collection. Interview recordings were analyzed to identify emerging themes. These themes were ranked according to the frequency with which they appeared, and main concepts identified by linking related themes. Most groups supported the use of genetically modified mosquitoes against Zika, but there were several varying concerns, including environmental worries and the impact of these organisms on humans. Many questioned the characteristics of Zika itself, and some believed Zika is a man-made virus created in a lab. Others doubted the link of Zika virus to microcephaly and other birth defects, and some were unsure if Zika virus is transmitted by mosquitoes. There is a wide range of differing knowledge, attitudes, and perceptions towards genetically modifying technology in general and towards mosquitoes in response to Zika.


Sign in / Sign up

Export Citation Format

Share Document